NO159089C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.

Info

Publication number
NO159089C
NO159089C NO852994A NO852994A NO159089C NO 159089 C NO159089 C NO 159089C NO 852994 A NO852994 A NO 852994A NO 852994 A NO852994 A NO 852994A NO 159089 C NO159089 C NO 159089C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogy procedure
glutarimide derivatives
active glutarimide
Prior art date
Application number
NO852994A
Other languages
English (en)
Norwegian (no)
Other versions
NO852994L (no
NO159089B (no
Inventor
Marcel Hibert
Maurice Ward Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO852994L publication Critical patent/NO852994L/no
Publication of NO159089B publication Critical patent/NO159089B/no
Publication of NO159089C publication Critical patent/NO159089C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO852994A 1984-07-30 1985-07-29 Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. NO159089C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63539484A 1984-07-30 1984-07-30

Publications (3)

Publication Number Publication Date
NO852994L NO852994L (no) 1986-01-31
NO159089B NO159089B (no) 1988-08-22
NO159089C true NO159089C (no) 1988-11-30

Family

ID=24547629

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852994A NO159089C (no) 1984-07-30 1985-07-29 Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.

Country Status (19)

Country Link
EP (1) EP0170213B1 (fi)
JP (1) JPH0631222B2 (fi)
KR (1) KR880002625B1 (fi)
AR (1) AR241161A1 (fi)
AT (1) ATE49409T1 (fi)
AU (1) AU578962B2 (fi)
CA (1) CA1244418A (fi)
DE (1) DE3575301D1 (fi)
DK (1) DK163304C (fi)
ES (1) ES8604151A1 (fi)
FI (1) FI84178C (fi)
GR (1) GR851835B (fi)
HU (1) HU197002B (fi)
IE (1) IE58073B1 (fi)
IL (1) IL75901A (fi)
NO (1) NO159089C (fi)
NZ (1) NZ212856A (fi)
PT (1) PT80859B (fi)
ZA (1) ZA855563B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4696927A (en) * 1986-03-05 1987-09-29 Merrell Dow Pharmaceuticals Inc. 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives
US4704389A (en) * 1986-03-05 1987-11-03 Merrell Dow Pharmaceuticals Inc. Aromatic omega-alkyl-imino-tetrahydro-6H-1,3-thiazin-6-one derivatives
PH25227A (en) * 1986-03-05 1991-03-27 Merrell Dow France Et Co Aromatic w-alkylamino-tetrahydro-6h-1,3-thiazin-6-one derivatives, pharmaceutical composition containing same and method of use thereof
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
US5158956A (en) * 1990-05-04 1992-10-27 Eli Lilly And Company Method of inhibiting gastric acid secretion with benzodioxanes
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
HU9301856D0 (en) * 1990-12-24 1993-09-28 Merrell Dow Pharma Application of glutarimide derivatives for treating depressive and maniacal diseases
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
WO1992020338A1 (en) * 1991-05-10 1992-11-26 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
US5221745A (en) * 1991-06-21 1993-06-22 American Home Products Corp. Psychotropic piperidinylmethyl benzodioxans
US5182292A (en) * 1991-06-21 1993-01-26 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5189171A (en) * 1991-06-21 1993-02-23 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5126366A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Aminophenoxyalkyl derivatives of benzodioxan
US5212170A (en) * 1991-06-21 1993-05-18 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5126367A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Psychotropic benzodioxan derivatives
US5166367A (en) * 1991-06-21 1992-11-24 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5134140A (en) * 1991-06-21 1992-07-28 American Home Products Corporation Psychotropic benzofuran derivatives
FR2678617B1 (fr) * 1991-07-01 1995-01-20 Adir Nouveau procede de synthese d'enantiomeres de derives du 3-amino chromane.
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
JP3136206B2 (ja) * 1991-10-22 2001-02-19 中外製薬株式会社 ベンゾジオキサン誘導体
ZA931343B (en) * 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
US5245051A (en) * 1992-09-03 1993-09-14 American Home Products Corporation Antipsychotic chroman derivatives of benzodioxanmethylamine
GB9305672D0 (en) * 1993-03-19 1993-05-05 Wyeth John & Brother Ltd Amide derivatives
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
WO2005110984A1 (ja) * 2004-05-17 2005-11-24 Daicel Chemical Industries, Ltd. N−ヒドロキシ環状イミド化合物の製造法
EP2236511A4 (en) 2007-12-21 2011-04-13 Alla Chem Llc LIGANDS OF ALPHA ADRENOCEPTORS AND OF DOPAMINE, HISTAMIN, IMIDAZOLIN AND SEROTONIN RECEPTORS AND THEIR APPLICATION THEREOF
KR102022154B1 (ko) * 2016-11-24 2019-09-18 한양대학교 산학협력단 MBD2-p66α(GATAD2A)의 상호작용을 억제하는 화합물을 포함하는 암 전이 억제 및 암 질환 예방 및 치료용 조성물

Also Published As

Publication number Publication date
DK163304B (da) 1992-02-17
PT80859A (en) 1985-08-01
NO852994L (no) 1986-01-31
ES545558A0 (es) 1986-01-16
DE3575301D1 (de) 1990-02-15
IL75901A0 (en) 1985-12-31
AR241161A2 (es) 1991-12-30
KR860001103A (ko) 1986-02-22
FI852922L (fi) 1986-01-31
IL75901A (en) 1988-11-15
DK163304C (da) 1992-07-06
FI84178C (fi) 1991-10-25
ATE49409T1 (de) 1990-01-15
AU4535385A (en) 1986-02-06
IE58073B1 (en) 1993-06-30
EP0170213A1 (en) 1986-02-05
CA1244418A (en) 1988-11-08
DK344085A (da) 1986-01-31
AU578962B2 (en) 1988-11-10
HU197002B (en) 1989-02-28
DK344085D0 (da) 1985-07-29
NZ212856A (en) 1988-05-30
ES8604151A1 (es) 1986-01-16
IE851870L (en) 1986-01-30
GR851835B (fi) 1985-12-02
AR241161A1 (es) 1991-12-30
JPH0631222B2 (ja) 1994-04-27
JPS61246180A (ja) 1986-11-01
PT80859B (pt) 1987-09-18
FI852922A0 (fi) 1985-07-26
NO159089B (no) 1988-08-22
EP0170213B1 (en) 1990-01-10
KR880002625B1 (ko) 1988-12-07
FI84178B (fi) 1991-07-15
HUT38338A (en) 1986-05-28
ZA855563B (en) 1986-05-28

Similar Documents

Publication Publication Date Title
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO895086D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO167284C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksazol- og isoksazolderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2001